Samsung Biologics
207940.KS
£587.41
Share price
0.09%
Change (1 day)
10.81%
Change (1 year)
Categories
Revenue for Samsung Biologics (207940.KS)
Revenue in 2025 (TTM): £2.70 Billion
According to Samsung Biologics
's latest financial reports the company's current revenue (TTM 
) is £2.60 Billion. In 2024 the company made a revenue of £2.63 Billion an increase over the revenue in the year 2023 that were of £2.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Samsung Biologics from 2016 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | £2.70 B | 2.74% |
| 2024 | £2.63 B | 19.44% |
| 2023 | £2.20 B | 15.87% |
| 2022 | £1.90 B | 89.97% |
| 2021 | £1.00 B | 35.22% |
| 2020 | £0.73 B | 60.86% |
| 2019 | £0.45 B | 19.91% |
| 2018 | £0.38 B | 23.69% |
| 2017 | £0.31 B | 50.32% |
| 2016 | £0.20 B |